Blood clusterin levels have been shown to change in different disease states including numerous cancers [34] and systemic lupus erythematosus [35] as well as in diabetic type II patients and in patients with developing coronary heart disease, or myocardial infarction [36]. This evidence concerns the gene CLU and cancer.